Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Star Retina is an ophthalmology practice specializing in diseases of the retina and vitreous. The clinic serves as an active investigational site for multiple sponsor-led Phase 2 and Phase 3 clinical trials targeting common retinal conditions such as diabetic macular edema, neovascular age-related macular degeneration, geographic atrophy secondary to AMD, diabetic retinopathy, and retinal vein occlusion. It does not develop its own drugs or devices but contributes to advancing new treatments through patient recruitment and study execution. Clinical results pertain to sponsor products rather than any proprietary pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Star Retina.